Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Biochem Genet. 2024 Aug;62(4):2667-2685. doi: 10.1007/s10528-023-10548-w. Epub 2023 Nov 24.
Preeclampsia is the most common and serious complication of pregnancy. Variants of Sirtuin-1 (SIRT1) as a key player in the regulation of oxidant/antioxidant signaling pathways might be involved in the pathogenesis of preeclampsia. In the present case-control study 300 women with and without preeclampsia were studied for SIRT1 variants (rs7895833, rs7069102, and rs2273773) and haplotypes. Also, the relationship of glutathione peroxidase (GPx) and superoxide dismutase (SOD) activities and Zn, Cu, and Se levels to the polymorphisms were investigated. The SIRT1 rs7895833 A > G, rs7069102 C > G, and the rs2273773 C > T polymorphisms were associated with the risk of preeclampsia. We found the haplotypes G (rs7895833) C (rs7069102) C (rs2273773), GCC, and ACC compared to the AGT decreased the risk of preeclampsia. The risk haplotype of AGT was associated with higher GPx activity compared to the GCC haplotype. A significantly higher level of Cu and lower levels of Zn and Se in patients with preeclampsia compared to controls were detected. Also, a significantly lower SOD and higher GPx activity in preeclamptic patients compared to controls were found. The three risk genotypes of AA (rs7895833), GG (rs7069102), and TT (rs2273773) significantly decreased the Zn level and SOD activity, and the TT genotype (rs2273773) increased the Cu level in all studied women. The presence of rs7069102 polymorphism was associated with enhanced systolic blood pressure. For the first time, we indicated three SIRT1 polymorphisms and the AGT haplotype are risk factors for preeclampsia development. Also, SIRT1 variants and haplotypes affect the levels of antioxidant enzymes and their cofactors, complicating the pregnancy outcome.
子痫前期是妊娠中最常见和最严重的并发症。沉默调节蛋白-1(SIRT1)作为氧化应激/抗氧化信号通路调节的关键因子,其变体可能参与子痫前期的发病机制。在本病例对照研究中,对 300 名患有和不患有子痫前期的妇女进行了 SIRT1 变体(rs7895833、rs7069102 和 rs2273773)和单倍型的研究。此外,还研究了谷胱甘肽过氧化物酶(GPx)和超氧化物歧化酶(SOD)活性以及锌、铜和硒水平与多态性的关系。SIRT1 rs7895833 A>G、rs7069102 C>G 和 rs2273773 C>T 多态性与子痫前期的发病风险相关。我们发现与 AGT 相比,G (rs7895833) C (rs7069102) C (rs2273773)、GCC 和 ACC 单倍型降低了子痫前期的发病风险。与 GCC 单倍型相比,AGT 风险单倍型与较高的 GPx 活性相关。与对照组相比,子痫前期患者的铜水平显著升高,锌和硒水平显著降低。与对照组相比,子痫前期患者的 SOD 活性显著降低,GPx 活性显著升高。AA(rs7895833)、GG(rs7069102)和 TT(rs2273773)三个风险基因型显著降低了所有研究女性的锌水平和 SOD 活性,TT 基因型(rs2273773)增加了铜水平。rs7069102 多态性的存在与收缩压升高有关。我们首次表明,SIRT1 三个多态性和 AGT 单倍型是子痫前期发展的危险因素。此外,SIRT1 变体和单倍型影响抗氧化酶及其辅因子的水平,使妊娠结局复杂化。